@prefix : <https://purl.org/heals/gprov-kg#> .
@prefix ns: <http://www.w3.org/2003/06/sw-vocab-status/ns#> .
@prefix sm: <http://www.omg.org/techprocess/ab/SpecificationMetadata/> .
@prefix dct: <http://purl.org/dc/terms/> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix sio: <http://semanticscience.org/resource/> .
@prefix xml: <http://www.w3.org/XML/1998/namespace> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .
@prefix bibo: <http://purl.org/ontology/bibo/> .
@prefix core: <http://purl.org/vocab/frbr/core#> .
@prefix prov: <https://www.w3.org/ns/prov#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix skos: <http://www.w3.org/2004/02/skos/core#> .
@prefix event: <http://purl.org/NET/c4dm/event.owl#> .
@prefix gprov: <https://purl.org/heals/gprov> .
@prefix prov1: <http://www.w3.org/ns/prov#> .
@base <https://purl.org/heals/gprov> .

:DMTO_Rule_1 a gprov:FormalRule;
             prov:wasDerivedFrom :ADA_Recommendation_2020_9_4 .

:ADA_Recommendation_2020_9_4 a gprov:Recommendation ;
                        prov:wasRevisionOf :ADA_Recommendation_2019_9_5 ;
                        prov:wasGeneratedBy :EvidenceSentence_2020_9_4;
                        sio:hasAttribute :ADA_Recommendation_2020_9_4_Grade ;
                        prov:hadPrimarySource :ADA_Guidelines_2020 ;
                        dct:isPartOf :ADA_Guidelines_2020 ;
                        sio:hasValue "Metformin is the preferred initial pharmacologic agent for the treatment of type 2 diabetes.".
                        
:EvidenceSentence_2020_9_4 a gprov:EvidenceSentence;
                    sio:hasValue "Metformin should be started at the time type 2 diabetes is diagnosed unless there are contraindications; for many patients this will be monotherapy in combination with lifestyle modifications. Metformin is effective and safe, is inexpensive, and may reduce risk of cardiovascular events and death (35)." ;
                    prov:wasInfluencedBy :ADA_Recommendation_2020_9_4_Grade;
                    prov:hadPrimarySource :ADA_Recommendation_Citation_1.

:ADA_Recommendation_Citation_1 a gprov:Citation;
                    sio:hasValue "Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HAW. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med 2008;359:1577â€“1589";
                    a bibo:Article;
                    bibo:pageEnd "1589";
                    bibo:pageStart "1577";
                    bibo:volume "NEJMoa0806470";
                    dct:date "October 9, 2008";
                    dct:publisher "The New England Journal of Medicine";
                    dct:title "10-Year Follow-up of Intensive Glucose Control in Type 2 Diabetes";
                    gprov:authorList "Rury R. Holman, F.R.C.P., Sanjoy K. Paul, Ph.D., M. Angelyn Bethel, M.D., David R. Matthews, F.R.C.P., and H. Andrew W. Neil, F.R.C.P.".
                        
:ADA_Recommendation_2020_9_4_Grade a gprov:Grade;
                    sio:hasValue "A" .

:ADA_Guidelines_2020 dct:year "2020"; 
                dct:title "American Diabetes Association Standards of Medical Care in Diabetes" ;
                bibo:volume "43" ;
                bibo:contributorList :ADA_Guidelines_Author;
                bibo:uri "https://care.diabetesjournals.org/content/43/Supplement_1".

:ADA_Guidelines_Author a gprov:Author;
                            sio:hasValue "American Diabetes Association".

:ADA_Recommendation_2019_9_5 a gprov:Recommendation ;
                        prov:wasGeneratedBy :EvidenceSentence_2019_9_5;
                        sio:hasAttribute :ADA_Recommendation_2019_9_5_Grade;
                        prov:hadPrimarySource :ADA_Guidelines_2019 ;
                        dct:isPartOf :ADA_Guidelines_2019;
                        sio:hasValue "Metformin is the preferred initial pharmacologic agent for the treatment of type 2 diabetes.".

:EvidenceSentence_2019_9_5 a gprov:EvidenceSentence;
                    sio:hasValue "Metformin should be started at the time type 2 diabetes is diagnosed unless there are contraindications; for most patients this will be monotherapy in combination with lifestyle modifications. Metformin is effective and safe, is inexpensive, and may reduce risk of cardiovascular events and death (40)." ;
                    prov:wasInfluencedBy :ADA_Recommendation_2020_9_4_Grade;
                    prov:hadPrimarySource :ADA_Recommendation_Citation_1.

:ADA_Recommendation_2019_9_5_Grade a gprov:Grade;
                        sio:hasValue "A" .

:ADA_Guidelines_2019 dct:year "2019"; 
                dct:title "American Diabetes Association Standards of Medical Care in Diabetes" ;
                bibo:volume "42" ;
                bibo:contributorList :ADA_Guidelines_Author;
                bibo:uri "https://care.diabetesjournals.org/content/42/Supplement_1".
